Status:
UNKNOWN
Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder
Lead Sponsor:
Pharmacology Research Institute
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to evaluate the effectiveness, safety and tolerability of an escitalopram combination treatment compared to single treatments, and to placebo in patients with major depres...
Detailed Description
Both active drugs being tested, alone and in combination, in this study are currently available antidepressants. However, the doses used in this study are lower than the standard approved doses.
Eligibility Criteria
Inclusion
- Patients must meet Diagnostic and Statistical Manual, Fourth Edition (DSM-IV) diagnostic criteria for Major Depressive Disorder
- The patient's current depressive episode must be at least 12 weeks in duration.
Exclusion
- Women who are pregnant, women who will be breastfeeding during the study, and women of childbearing potential who are not practicing a reliable method of birth control.
- Patients who currently meet DSM-IV criteria for : a. bipolar disorder; b. schizophrenia or any psychotic disorder; c. obsessive-compulsive disorder; d. mental retardation or any pervasive developmental disorder or cognitive disorder.
- Patients who are considered a suicide risk.
- Patients with a history of seizure disorder, or any history of seizure, stroke, significant head injury, or any other condition that predisposes toward risk of seizure.
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00239954
Start Date
March 1 2005
Last Update
May 9 2012
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Pharmacology Research Institute
Los Alamitos, California, United States, 90720
2
Pharmacology Research Institute
Newport Beach, California, United States, 92660
3
Pharmacology Research Institute
Northridge, California, United States, 91324
4
Pharmacology Research Institute
Riverside, California, United States, 92506